2023 - Research.com Medicine in Spain Leader Award
The scientist’s investigation covers issues in Internal medicine, Cervical cancer, Gynecology, HPV infection and Cancer. The study incorporates disciplines such as Oncology and Vaccine efficacy in addition to Internal medicine. Xavier Castellsagué usually deals with Cervical cancer and limits it to topics linked to Immunology and Papillomavirus Vaccines and Genital warts.
His study in Gynecology is interdisciplinary in nature, drawing from both Human Papillomavirus DNA Test, Retrospective cohort study, Genotyping, Genotype and Vulva. His Cancer research includes elements of Epidemiology, Risk factor, Pathology and Chlamydia trachomatis. His Epidemiology study combines topics in areas such as Odds ratio and Head and neck cancer.
His main research concerns Internal medicine, Gynecology, Cancer, Cervical cancer and Epidemiology. Within one scientific family, Xavier Castellsagué focuses on topics pertaining to Oncology under Internal medicine, and may sometimes address concerns connected to Genotyping and Retrospective cohort study. His Gynecology study incorporates themes from Incidence, Cervix, Papillomaviridae, Obstetrics and HPV infection.
His biological study spans a wide range of topics, including Odds ratio, Case-control study, Pathology, Cancer research and Dentistry. Xavier Castellsagué works mostly in the field of Odds ratio, limiting it down to topics relating to Risk factor and, in certain cases, Environmental health. His Cervical cancer research integrates issues from Clinical trial and Human papillomavirus.
His primary scientific interests are in Internal medicine, Oncology, Cancer, Gynecology and Head and neck cancer. His Odds ratio, Incidence, Case-control study, Confidence interval and HPV infection study are his primary interests in Internal medicine. His Oncology research includes themes of Retrospective cohort study, Pathology, Carcinoma, Confounding and Surrogate endpoint.
He works mostly in the field of Cancer, limiting it down to concerns involving Vulva and, occasionally, Anus and Vagina. His research in Gynecology intersects with topics in Cervical cancer, Cervical intraepithelial neoplasia, Anal cancer and Cervix. The concepts of his Head and neck cancer study are interwoven with issues in Attributable risk, Epidemiology, Head and neck, Larynx and Socioeconomic status.
Xavier Castellsagué mostly deals with Internal medicine, Case-control study, Oncology, Vaccination and Young adult. His Internal medicine research is multidisciplinary, relying on both Imputation and Allele. The concepts of his Case-control study study are interwoven with issues in Odds ratio, Socioeconomic status, Head and neck cancer and Epidemiology.
His studies deal with areas such as Retrospective cohort study, Genotyping, Carcinoma, Gynecology and HPV vaccines as well as Oncology. Xavier Castellsagué interconnects Cervical cancer, Cervical intraepithelial neoplasia and Randomized controlled trial in the investigation of issues within Vaccination. His study in Young adult is interdisciplinary in nature, drawing from both Incidence and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
Nubia Muñoz;F. Xavier Bosch;Silvia de Sanjosé;Rolando Herrero.
The New England Journal of Medicine (2003)
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjose;Wim G.V. Quint;Laia Alemany;Daan T. Geraets.
Lancet Oncology (2010)
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
J. Paavonen;P. Naud;J. Salmeron;C. M. Wheeler.
The Lancet (2009)
HPV in the etiology of human cancer
Nubia Munoz;Xavier Castellsague;Amy Berrington De Gonzalez;Lutz Gissmann.
Vaccine. Supplement (2006)
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.
Silvia de Sanjosé;Mireia Diaz;Xavier Castellsagué;Gary Clifford.
Lancet Infectious Diseases (2007)
Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial
Jorma Paavonen;David Jenkins;F. Xavier Bosch;Paulo Naud.
The Lancet (2007)
Against which human papillomavirus types shall we vaccinate and screen? The international perspective.
Nubia Muñoz;F. Xavier Bosch;Xavier Castellsagué;Mireia Díaz.
International Journal of Cancer (2004)
Environmental co-factors in HPV carcinogenesis.
Xavier Castellsagué;F.Xavier Bosch;Nubia Muñoz.
Virus Research (2002)
Chapter 1: HPV in the etiology of human cancer.
Nubia Muñoz;Xavier Castellsagué;Amy Berrington de González;Lutz Gissmann.
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
Rolando Herrero;Xavier Castellsagué;Michael Pawlita;Jolanta Lissowska.
Journal of the National Cancer Institute (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: